Human TREM2 Antibody

Discontinued Product

AF1828 has been discontinued.
View all TREM2 products.
Detection of Human TREM2 by Western Blot.
4 Images
Product Details
Citations (32)
FAQs
Reviews (4)

Human TREM2 Antibody Summary

Species Reactivity
Human
Specificity
Detects human TREM2 in direct ELISAs and Western blots. In direct ELISAs, less than 50% cross-reactivity with recombinant mouse TREM2b is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TREM2
His19-Ser174
Accession # Q9NZC2
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.2 µg/mL
See below
ELISA

This antibody functions as an ELISA detection antibody when paired with Mouse Anti-Human TREM2 Monoclonal Antibody.

This product is intended for assay development on various assay platforms requiring antibody pairs. We recommend the Human TREM2 DuoSet ELISA Kit (Catalog # DY1828-05) for convenient development of a sandwich ELISA.

 
Flow Cytometry
2.5 µg/106 cells
Human peripheral blood monocytes
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 
Immunocytochemistry
5-15 µg/mL
See below

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Human TREM2 antibody by Western Blot. View Larger

Detection of Human TREM2 by Western Blot. Western blot shows lysates of THP-1 human acute monocytic leukemia cell line. PVDF membrane was probed with 0.2 µg/mL of Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for TREM2 at approximately 28 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Immunocytochemistry TREM2 antibody in Human Dendritic Cells by Immunocytochemistry (ICC). View Larger

TREM2 in Human Dendritic Cells. TREM2 was detected in immersion fixed immature human dendritic cells using Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Human TREM2 ELISA Standard Curve. Recombinant Human TREM2 protein was serially diluted 2-fold and captured by Mouse Anti-Human TREM2 Monoclonal Antibody(Catalog # MAB18281) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994).

Western Blot Detection of Human TREM2 by Western Blot View Larger

Detection of Human TREM2 by Western Blot TREM2 is shed at a single cleavage site in the ectodomain between histidine 157 and serine 158Regulated intramembrane proteolysis of TREM2. ADAM10 initiates proteolytic processing of TREM2 by liberating its ectodomain (sTREM2). Subsequent processing of the membrane retained C‐terminal fragment (CTF) by gamma ‐secretase within the transmembrane domain (TM) releases the intracellular domain (ICD) into the cytosol. A short p3‐like peptide (Haass et al, 1993) may be secreted.Outline of strategy I for mass spectrometric (MS) determination of the N‐terminal end of the TREM2 CTF enriched upon gamma ‐secretase inhibition using DAPT.Western blot analysis of TREM2 stably expressed in HEK293 Flp‐In cells upon gamma ‐secretase inhibition using DAPT. Application of DAPT leads to a robust accumulation of the TREM2 CTF under constitutive conditions as well as upon phorbol 12‐myristate 13‐acetate (PMA) mediated stimulation of TREM2 ectodomain shedding. The TREM2 9D11 antibody raised against the TREM2 C‐terminus was used to detect TREM2, and calnexin levels were analyzed as a loading control. Here, as in all other Western blots in Figs 1 and 2, the two lanes represent samples from two separate wells seeded at the same time.MALDI‐TOF MS determination of the ectodomain cleavage site by immunoprecipitation of TREM2 CTF. The peak at 8,841.48 Da corresponds to a single cleavage site between histidine 157 and serine 158. Very minor additional peaks may represent cellular degradation products, as the N‐terminal counterpart cannot be observed (see Fig 1I).Stimulation of ectodomain shedding by PMA leads to strong increases in sTREM2 (anti‐HA, upper panel) and sAPP alpha (2D8, lower panel). DMSO served as a vehicle control. EV, empty vector control.MALDI‐TOF MS determination of the ectodomain cleavage site upon ADAM17 stimulation using PMA. TREM2 CTFs were enriched by gamma ‐secretase inhibition using DAPT (Fig 1C). The peak at 8,837.09 Da corresponds to a single cleavage site between histidine 157 and serine 158.Outline of strategy II for MS determination of the C‐terminal end of sTREM2 generated by ectodomain shedding.Western blot analysis of full‐length TREM2‐TEVFlag (middle panel) and ectodomain shedding (upper panel) upon transient transfection of HEK293 Flp‐In cells. EV, empty vector control.MALDI‐TOF MS determination of the ectodomain cleavage site following the strategy outlined in Fig 1G. The peak at a mass of 3,947.78 Da corresponds to cleavage C‐terminal of histidine 157 and is absent in cells transfected with an empty expression vector.TREM2 is shed predominantly C‐terminal to histidine 157 as observed in two different cell types as well as under constitutive and PMA‐stimulated conditions.Western blot analysis of full‐length TREM2‐TEVFlag (middle panel) and ectodomain shedding (upper panel) upon transient transfection of THP‐1 monocytes.MALDI‐TOF MS determination of the ectodomain cleavage site in THP‐1 monocytes following the strategy outlined in Fig 1G. The peak at a mass of 3,943.80 Da corresponds to cleavage C‐terminal of histidine 157 and is absent in cells transfected with an empty expression vector.Source data are available online for this figure. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28855300), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: TREM2

TREM2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa molecular weight type I transmembrane member of the TREM family and Ig superfamily. Mature human TREM2 consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. Within the ECD, human TREM2 shares 73% and 74% aa sequence identity with mouse and rat TREM2, respectively. Two closely related transcripts were reported in mouse and designated TREM2a and TREM2b. Soluble forms of the TREM2 ECD are generated by alternative splicing or proteolytic cleavage, and the cytoplasmic domain can be liberated by gamma-Secretase mediated intramembrane cleavage. It is a pattern recognition receptor that binds anionic ligands. A positively charged lysine within the transmembrane segment allows association with the signal adapter protein, DAP12 to deliver an activating signal that plays a role in both innate and adaptive immune responses, including inhibition of macrophage activation. TREM2 is expressed on macrophages, immature myeloid dendritic cells, osteoclasts, microglia, and adipocytes. It promotes the differentiation and function of osteoclasts, the production of inflammatory cytokines by adipocytes, insulin resistance, and the phagocytic clearance of bacteria. In the CNS, TREM2 binds to ApoE, ApoA1, and ApoB and mediates the clearance of apoptotic neurons, amyloid plaques, and cell debris following demyelination. TREM2 also interacts with and modifies signaling through Plexin A1 on dendritic cells and osteoclasts. Mutations in TREM2 or DAP12 are associated with the development of Alzheimer's disease and Nasu-Hakola disease (NHD/PLOSL) which is characterized by presenile dementia and bone cysts. Soluble TREM2 is elevated in cerebrospinal fluid of patients with active multiple sclerosis (MS), and TREM2 blockade exacerbates disease symptoms in the experimental EAE model of MS.

Long Name
Triggering Receptor Expressed on Myeloid Cells 2
Entrez Gene IDs
54209 (Human); 102133279 (Cynomolgus Monkey)
Alternate Names
PLOSL2; TREM2; TREM-2; Trem2a; Trem2b; Trem2c; TREM-2triggering receptor expressed on myeloid cells 2a; Triggering receptor expressed on monocytes 2; triggering receptor expressed on myeloid cells 2

Product Datasheets

You must select a language.

x

Citations for Human TREM2 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

32 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Human induced pluripotent stem cell-derived microglia with a CX3CR1-V249I genetic variant exhibit dysfunctional phenotypes and modulate neuronal growth and function
    Authors: Tutrow, KD;Harkin, J;Varghese, L;Hernandez, M;Huang, KC;Fang, Y;Wilcox, P;Bedford, L;Lin, TY;Zhang, C;Gomes, C;Puntambekar, S;Bissel, S;Lamb, BT;Meyer, JS;
    bioRxiv : the preprint server for biology
    Species: Human
    Sample Types: Whole Cells
    Applications: Immunocytochemistry
  2. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease
    Authors: Wang, L;Nykänen, NP;Western, D;Gorijala, P;Timsina, J;Li, F;Wang, Z;Ali, M;Yang, C;Liu, M;Brock, W;Marquié, M;Boada, M;Alvarez, I;Aguilar, M;Pastor, P;Ruiz, A;Puerta, R;Orellana, A;Rutledge, J;Oh, H;Greicius, MD;Le Guen, Y;Perrin, RJ;Wyss-Coray, T;Jefferson, A;Hohman, TJ;Graff-Radford, N;Mori, H;Goate, A;Levin, J;Sung, YJ;Cruchaga, C;
    Molecular neurodegeneration
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  3. Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro
    Authors: Dolan, MJ;Therrien, M;Jereb, S;Kamath, T;Gazestani, V;Atkeson, T;Marsh, SE;Goeva, A;Lojek, NM;Murphy, S;White, CM;Joung, J;Liu, B;Limone, F;Eggan, K;Hacohen, N;Bernstein, BE;Glass, CK;Leinonen, V;Blurton-Jones, M;Zhang, F;Epstein, CB;Macosko, EZ;Stevens, B;
    Nature immunology
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  4. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models
    Authors: B van Lenger, L Zhan, D Xia, D Chan, D Joy, JI Park, D Tatarakis, M Calvert, S Hummel, S Lianoglou, ME Pizzo, R Prorok, E Thomsen, LM Bartos, P Beumers, A Capell, SS Davis, L de Weerd, JC Dugas, J Duque, T Earr, K Gadkar, T Giese, A Gill, J Gnörich, C Ha, M Kannuswamy, DJ Kim, ST Kunte, LH Kunze, D Lac, K Lechtenber, AW Leung, CC Liang, I Lopez, P McQuade, A Modi, VO Torres, HN Nguyen, I Pesämaa, N Propson, M Reich, Y Robles-Col, K Schlepckow, L Slemann, H Solanoy, JH Suh, RG Thorne, C Vieira, K Wind-Mark, K Xiong, YJY Zuchero, D Diaz, MS Dennis, F Huang, K Scearce-Le, RJ Watts, C Haass, JW Lewcock, G Di Paolo, M Brendel, PE Sanchez, KM Monroe
    Nature Neuroscience, 2023-01-12;0(0):.
    Species: Human
    Sample Types: Cell Lysates, Recombinant Protein
    Applications: Immunoprecipitation, Western Blot
  5. A reference human induced pluripotent stem cell line for large-scale collaborative studies
    Authors: CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendra, L Peng, H Oguro, J Kanaujiya, J Zou, D Sebesta, G Pratt, E Cross, J Blockwick, P Buxton, L Kinner-Bib, C Medura, C Tompkins, S Hughes, M Santiana, F Faghri, MA Nalls, D Vitale, S Ballard, YA Qi, DM Ramos, KM Anderson, J Stadler, P Narayan, J Papademetr, L Reilly, MP Nelson, S Aggarwal, LU Rosen, P Kirwan, V Pisupati, SL Coon, SW Scholz, T Priebe, M Öttl, J Dong, M Meijer, LJM Janssen, VS Lourenco, R van der Ka, D Crusius, D Paquet, AC Raulin, G Bu, A Held, BJ Wainger, RMC Gabriele, JM Casey, S Wray, D Abu-Bonsra, CL Parish, MS Beccari, DW Cleveland, E Li, IVL Rose, M Kampmann, C Calatayud, P Verstreken, L Heinrich, MY Chen, B Schüle, D Dou, ELF Holzbaur, MC Zanellati, R Basundra, M Deshmukh, S Cohen, R Khanna, M Raman, ZS Nevin, M Matia, J Van Lent, V Timmerman, BR Conklin, K Johnson Ch, K Zhang, S Funes, DA Bosco, L Erlebach, M Welzer, D Kronenberg, G Lyu, E Arenas, E Coccia, L Sarrafha, T Ahfeldt, JC Marioni, WC Skarnes, MR Cookson, ME Ward, FT Merkle
    Cell Stem Cell, 2022-12-01;29(12):1685-1702.e22.
    Species: Human
    Sample Types: Transfected Whole Cells
    Applications: ICC
  6. Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement
    Authors: Carmela Gallo, Emiliano Manzo, Giusi Barra, Laura Fioretto, Marcello Ziaco, Genoveffa Nuzzo et al.
    Cellular and Molecular Life Sciences
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  7. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice
    Authors: S Kiani Shab, S Morabito, EP Danhash, A McQuade, JR Sanchez, E Miyoshi, JP Chadarevia, C Claes, MA Coburn, J Hasselmann, J Hidalgo, KN Tran, AC Martini, W Chang Roth, J Pascual, E Head, DA Hume, C Pridans, H Davtyan, V Swarup, M Blurton-Jo
    Cell Reports, 2022-06-14;39(11):110961.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  8. PLCgamma2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages
    Authors: J Obst, HL Hall-Rober, TB Smith, M Kreuzer, L Magno, E Di Daniel, JB Davis, E Mead
    Scientific Reports, 2021-10-06;11(1):19842.
    Species: Human
    Sample Types: Whole Cells
    Applications: Functional Assay
  9. Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
    Authors: R Bassil, K Shields, K Granger, I Zein, S Ng, B Chih
    Nature Communications, 2021-09-01;12(1):5220.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  10. Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia
    Authors: J Wi beta feld, M Mathews, O Mossad, P Picardi, A Cinti, L Redaelli, L Pradier, O Brüstle, H Neumann
    Scientific Reports, 2021-06-29;11(1):13462.
    Species: Human
    Sample Types: Whole Cells
    Applications: Stimulation
  11. MEK1/2 activity modulates TREM2 cell surface recruitment
    Authors: J Schapansky, YY Grinberg, DM Osiecki, EA Freeman, SG Walker, E Karran, SM Gopalakris, RV Talanian
    The Journal of Biological Chemistry, 2020-12-25;296(0):100218.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  12. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages
    Authors: H Hall-Rober, D Agarwal, J Obst, TB Smith, J Monzón-San, E Di Daniel, C Webber, WS James, E Mead, JB Davis, SA Cowley
    Alzheimers Res Ther, 2020-11-16;12(1):151.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay, ICC, Western Blot
  13. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease
    Authors: A McQuade, YJ Kang, J Hasselmann, A Jairaman, A Sotelo, M Coburn, SK Shabestari, JP Chadarevia, G Fote, CH Tu, E Danhash, J Silva, E Martinez, C Cotman, GA Prieto, LM Thompson, JS Steffan, I Smith, H Davtyan, M Cahalan, H Cho, M Blurton-Jo
    Nat Commun, 2020-10-23;11(1):5370.
    Species: Human
    Sample Types: Cell Lysates, Whole Cells
    Applications: Functional Assay, Western Blot
  14. Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification
    Authors: AB Knapskog, K Henjum, AV Idland, RS Eldholm, K Persson, I Saltvedt, LO Watne, K Engedal, LNG Nilsson
    Sci Rep, 2020-09-28;10(1):15886.
    Species: Human
    Sample Types: CSF
    Applications: ELISA Capture
  15. Alzheimer's-associated PLCgamma2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
    Authors: BJ Andreone, L Przybyla, C Llapashtic, A Rana, SS Davis, B van Lenger, K Lin, J Shi, Y Mei, G Astarita, G Di Paolo, T Sandmann, KM Monroe, JW Lewcock
    Nat. Neurosci., 2020-06-08;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  16. A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture
    Authors: A Grubman, TH Vandekolk, J Schröder, G Sun, J Hatwell-Hu, J Chan, M Oksanen, S Lehtonen, C Hunt, JE Koistinaho, SK Nilsson, JM Haynes, CW Pouton, JM Polo
    Stem Cell Reports, 2020-05-21;14(6):1018-1032.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  17. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
    Authors: K Schlepckow, KM Monroe, G Kleinberge, L Cantuti-Ca, S Parhizkar, D Xia, M Willem, G Werner, N Pettkus, B Brunner, A Sülzen, B Nuscher, H Hampel, X Xiang, R Feederle, S Tahirovic, JI Park, R Prorok, C Mahon, CC Liang, J Shi, DJ Kim, H Sabelström, F Huang, G Di Paolo, M Simons, JW Lewcock, C Haass
    EMBO Mol Med, 2020-03-10;0(0):e11227.
    Species: Human
    Sample Types: Cell Culture Lysates
    Applications: Western Blot
  18. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model
    Authors: L Zhong, Y Xu, R Zhuo, T Wang, K Wang, R Huang, D Wang, Y Gao, Y Zhu, X Sheng, K Chen, N Wang, L Zhu, D Can, Y Marten, M Shinohara, CC Liu, D Du, H Sun, L Wen, H Xu, G Bu, XF Chen
    Nat Commun, 2019-03-25;10(1):1365.
    Species: Mouse
    Sample Types: Cell Lysates, Whole Tissue
    Applications: IHC, Western Blot
  19. Glial activation and inflammation along the Alzheimer's disease continuum
    Authors: K Nordengen, BE Kirsebom, K Henjum, P Selnes, B Gísladótti, M Wettergree, SB Torsetnes, GR Grøntvedt, KK Waterloo, D Aarsland, LNG Nilsson, T Fladby
    J Neuroinflammation, 2019-02-21;16(1):46.
    Species: Human
    Sample Types: CSF
    Applications: ELISA Development (Capture)
  20. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers A?42, t-tau and p-tau
    Authors: K Henjum, E Quist-Paul, H Zetterberg, K Blennow, LNG Nilsson, LO Watne
    J Neuroinflammation, 2018-11-03;15(1):304.
    Species: Human
    Sample Types: CSF
    Applications: ELISA Development (Capture)
  21. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
    Authors: P Garcia-Rei, A Phillips, TM Piers, C Villegas-L, M Butler, A Mallach, C Rodrigues, CE Arber, A Heslegrave, H Zetterberg, H Neumann, S Neame, H Houlden, J Hardy, JM Pocock
    Cell Rep, 2018-08-28;24(9):2300-2311.
    Species: Human
    Sample Types:
  22. Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation
    Authors: M Yanaizu, K Sakai, Y Tosaki, Y Kino, JI Satoh
    Sci Rep, 2018-05-02;8(1):6937.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  23. TREM2 Is a Receptor for ?-Amyloid that Mediates Microglial Function
    Authors: Y Zhao, X Wu, X Li, LL Jiang, X Gui, Y Liu, Y Sun, B Zhu, JC Piña-Cresp, M Zhang, N Zhang, X Chen, G Bu, Z An, TY Huang, H Xu
    Neuron, 2018-03-07;97(5):1023-1031.e7.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  24. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
    Authors: CYD Lee, A Daggett, X Gu, LL Jiang, P Langfelder, X Li, N Wang, Y Zhao, CS Park, Y Cooper, I Ferando, I Mody, G Coppola, H Xu, XW Yang
    Neuron, 2018-03-07;97(5):1032-1048.e5.
    Species: Transgenic Mouse
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  25. Intracellular trafficking of TREM2 is regulated by presenilin 1
    Authors: Y Zhao, X Li, T Huang, LL Jiang, Z Tan, M Zhang, IH Cheng, X Wang, G Bu, YW Zhang, Q Wang, H Xu
    Exp. Mol. Med., 2017-12-01;49(12):e405.
    Species: Human
    Sample Types: Protein
    Applications: Western Blot
  26. TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
    Authors: P Thornton, J Sevalle, MJ Deery, G Fraser, Y Zhou, S Ståhl, EH Franssen, RB Dodd, S Qamar, B Gomez Pere, LS Nicol, S Eketjäll, J Revell, C Jones, A Billinton, PH St George-, I Chessell, DC Crowther
    EMBO Mol Med, 2017-10-01;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  27. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
    Authors: K Schlepckow, G Kleinberge, A Fukumori, R Feederle, SF Lichtentha, H Steiner, C Haass
    EMBO Mol Med, 2017-10-01;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  28. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells
    Authors: MM Varnum, KA Clayton, A Yoshii-Kit, G Yonemoto, L Koro, S Ikezu, T Ikezu
    J. Biol. Chem., 2017-05-10;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Functional Assay
  29. TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation
    Sci Rep, 2016-12-09;6(0):38761.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  30. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors.
    Authors: Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB
    J. Immunol., 2009-11-04;183(11):7223-33.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  31. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.
    Authors: Park-Min KH, Ji JD, Antoniv T, Reid AC, Silver RB, Humphrey MB, Nakamura M, Ivashkiv LB
    J. Immunol., 2009-07-22;183(4):2444-55.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  32. TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.
    Authors: Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA
    Mucosal Immunol, 2008-03-05;1(3):229-38.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs

Reviews for Human TREM2 Antibody

Average Rating: 4.8 (Based on 4 Reviews)

5 Star
75%
4 Star
25%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human TREM2 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human TREM2 Antibody
By Anonymous on 06/07/2023
Application: Immunocytochemistry/Immunofluorescence Sample Tested: 293T human embryonic kidney cell line Species: Human

HEK293T cell stably expressing human TREM2


Human TREM2 Antibody
By Anonymous on 11/04/2021
Application: Immunocytochemistry/Immunofluorescence Sample Tested: Melanoma tissue Species: Human

Human TREM-2 Antibody
By Dennis Berner on 06/08/2017
Application: WB Sample Tested: HEK293T human embryonic kidney cell line Species: Human

Human TREM-2 Antibody
By Ju Shi on 05/16/2017
Application: Flow Sample Tested: 293T human embryonic kidney cell line Species: Human